U.S. flag

An official website of the United States government

NM_001142966.3(GREB1L):c.705G>T (p.Trp235Cys) AND Renal hypodysplasia/aplasia 3

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Apr 20, 2021
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001374712.2

Allele description [Variation Report for NM_001142966.3(GREB1L):c.705G>T (p.Trp235Cys)]

NM_001142966.3(GREB1L):c.705G>T (p.Trp235Cys)

Genes:
GREB1L:GREB1 like retinoic acid receptor coactivator [Gene - OMIM - HGNC]
LOC101927521:uncharacterized LOC101927521 [Gene]
Variant type:
single nucleotide variant
Cytogenetic location:
18q11.1
Genomic location:
Preferred name:
NM_001142966.3(GREB1L):c.705G>T (p.Trp235Cys)
HGVS:
  • NC_000018.10:g.21401322G>T
  • NM_001142966.3:c.705G>TMANE SELECT
  • NP_001136438.1:p.Trp235Cys
  • NC_000018.9:g.18981283G>T
Protein change:
W235C; TRP235CYS
Links:
OMIM: 617782.0019; dbSNP: rs2144522176
NCBI 1000 Genomes Browser:
rs2144522176
Molecular consequence:
  • NM_001142966.3:c.705G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Renal hypodysplasia/aplasia 3 (RHDA3)
Identifiers:
MONDO: MONDO:0024520; MedGen: C4540497; OMIM: 617805

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001571641OMIM
no assertion criteria provided
Pathogenic
(Apr 20, 2021)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Whole-exome sequencing identifies a GREB1L variant in a three-generation family with Müllerian and renal agenesis: a novel candidate gene in Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome. A case report.

Herlin MK, Le VQ, Højland AT, Ernst A, Okkels H, Petersen AC, Petersen MB, Pedersen IS.

Hum Reprod. 2019 Sep 29;34(9):1838-1846. doi: 10.1093/humrep/dez126.

PubMed [citation]
PMID:
31424080

Details of each submission

From OMIM, SCV001571641.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In all affected members of a 3-generation family with renal agenesis and/or uterovaginal agenesis (RHDA3; 617805), Herlin et al. (2019) identified heterozygosity for a c.705G-T transversion (c.705G-T, NM_001142966) in the GREB1L gene, resulting in a trp235-to-cys (W235C) substitution at a highly conserved residue. The mutation, which was not found in the gnomAD database, was present in 2 unaffected sisters (II-2 and II-4) who had inherited it from their affected father (I-3) and transmitted it to their affected offspring (III-1, III-2, III-3, and III-5), suggesting that the variant is penetrant only when maternally inherited. However, their brother (II-5), who also carried the mutation and had transmitted it to an unaffected daughter, had multicystic kidney disease. The authors suggested that the latter was an independent finding with no association to GREB1L; thus the pedigree would represent autosomal dominant inheritance with incomplete penetrance in a parent-origin-specific manner, possibly due to imprinting.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 24, 2023